Chemoinformaics analysis of GAMMA-GLUTAMYL-S-METHYLCYSTEINE-SULFOXIDE
| Molecular Weight | 280.302 | nRot | 8 |
| Heavy Atom Molecular Weight | 264.174 | nRig | 3 |
| Exact Molecular Weight | 280.073 | nRing | 0 |
| Solubility: LogS | -1.256 | nHRing | 0 |
| Solubility: LogP | -3.752 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 35.6107 |
| nHD | 4 | BPOL | 23.2133 |
| QED | 0.38 |
| Synth | 4.003 |
| Natural Product Likeliness | 0.495 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.987 |
| HIA | 0.025 |
| CACO-2 | -6.418 |
| MDCK | 0.00173506 |
| BBB | 0.239 |
| PPB | 0.110798 |
| VDSS | 0.339 |
| FU | 0.823315 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.039 |
| CYP2c9-inh | 0.065 |
| CYP2c9-sub | 0.63 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.114 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.003 |
| CL | 2.239 |
| T12 | 0.729 |
| hERG | 0.009 |
| Ames | 0.039 |
| ROA | 0.003 |
| SkinSen | 0.15 |
| Carcinogencity | 0.191 |
| EI | 0.039 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.726836 |